Ironwood Pharmaceuticals | IRWD - 流动资产



金融业
股票价格
USD 3.50
资产
USD 434.57M
现金及等价物
USD 220.47M
销售成本
USD 29.83M
流动资产
USD 332.29M
流动负债
USD 236.31M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD 0.31
股本和储备
USD -217.14M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 556.5M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 113.04M
销售和管理费用
USD 33.33M
贸易债权人
USD 3.24M
应收帐款人
USD 81.89M


流动资产 更改 日
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Almirall EUR 747.1M 33.12M 2026-06
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amarin USD 612.88M 10.12M 2026-09
Ardelyx USD 381.87M 447K 2026-03
Astellas Pharma JPY 1.49T 63.68B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Charles River Laboratories USD 1.53B 40.3M 2026-06
Coherus Biosciences USD 133.79M 72.25M 2026-06
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Incyte USD 5.52B 505.2M 2026-09
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
MacroGenics USD 321.69M 139.16M 2026-06
Moderna USD 5.82B 45M 2026-06
Myriad Genetics USD 289M 23.8M 2026-06
Pacira USD 615.21M 100.25M 2026-06
PTC Therapeutics USD 2.54B 79.58M 2026-09
Puma Biotechnology USD 143.58M 7M 2025-09
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Takeda JPY 3T 153.11B 2026-09
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12